Jan 19, 2021 07:00AM
Dec 17, 2020 07:00AM
Aug 20, 2020 04:05PM
Aug 20, 2020 04:05PM
Aug 5, 2020 04:05PM
Jul 23, 2020 04:34PM
Jul 23, 2020 04:32PM Cobomarsen Receives Orphan Drug Designation From the U.S. FDA for the Treatment of T-cell Lymphoma
Jul 22, 2020 06:03PM
Jun 17, 2020 09:27AM
Jun 16, 2020 05:20PM
May 7, 2020 04:05PM
Mar 11, 2020 04:05PM
Jan 31, 2020 06:39AM
Jan 30, 2020 07:18AM miRagen Therapeutics (MGEN) Announces Positive Data for Cobomarsen in Adult T-Cell Leukemia/lymphoma Patients With Residual Disease
Jan 30, 2020 07:00AM
Dec 17, 2019 07:15AM
Dec 11, 2019 04:05PM
Oct 28, 2019 09:00AM
Aug 7, 2019 04:05PM
May 8, 2019 04:01PM
Mar 13, 2019 04:05PM miRagen Announces Fourth Quarter and Full Year 2018 Financial Results and Provides 2019 Outlook
Jan 10, 2019 07:03AM
Jan 10, 2019 07:00AM
Dec 20, 2018 07:00AM
Dec 3, 2018 05:56AM
Dec 2, 2018 05:00PM
Nov 7, 2018 04:01PM
Aug 7, 2018 04:05PM miRagen Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
Jun 4, 2018 07:30AM
May 9, 2018 04:05PM
Mar 29, 2018 09:10AM
Mar 14, 2018 04:05PM
Mar 9, 2018 09:23AM
Feb 2, 2018 07:00AM
Aug 11, 2017 04:05PM miRagen Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update
May 24, 2017 07:05AM
May 24, 2017 07:00AM
May 10, 2017 04:05PM
Apr 20, 2017 07:00AM
Mar 31, 2017 04:05PM
Mar 31, 2017 07:24AM
Mar 31, 2017 07:00AM miRagen Therapeutics Receives Orphan-Drug Designation for MRG-106 for the Treatment of Mycosis Fungoides

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All